Hangzhou Tigermed Consulting (03347) had repurchased a total of 9.8063 million A shares as of the end of February.

Hangzhou Tigermed Consulting (03347) announced that as of February 28, 2025, the company has repurchased a total of 9.8063 million shares through the special securities account for stock repurchases via centralized bidding trading, representing 1.1337% of the company's total share capital and 1.3219% of the company's A share total share capital. The highest transaction price was 62.00 yuan per share, the lowest transaction price was 48.17 yuan per share, and the total transaction amount was 500 million yuan (excluding transaction fees).